These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 63749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.
    Hussain MA, Green N, Flynn DM, Hoffbrand AV.
    Lancet; 1977 May 07; 1(8019):977-9. PubMed ID: 67469
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R, Thévenin M, Bouveret JP, Jeannel F, Rymer JC.
    Arch Fr Pediatr; 1980 Apr 07; 37(4):241-7. PubMed ID: 7406638
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
    Olivieri NF, Koren G, Hermann C, Bentur Y, Chung D, Klein J, St Louis P, Freedman MH, McClelland RA, Templeton DM.
    Lancet; 1990 Nov 24; 336(8726):1275-9. PubMed ID: 1978115
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Continuous subcutaneous administration of deferoxamine in patients with iron overload.
    Propper RD, Cooper B, Rufo RR, Nienhuis AW, Anderson WF, Bunn HF, Rosenthal A, Nathan DG.
    N Engl J Med; 1977 Aug 25; 297(8):418-23. PubMed ID: 882111
    [Abstract] [Full Text] [Related]

  • 10. Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.
    Pippard MJ, Callender ST, Weatherall DJ.
    Clin Sci Mol Med; 1978 Jan 25; 54(1):99-106. PubMed ID: 620500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ, Aldouri MA, Hoffbrand AV, Barr J, Wonke B, Kourouclaris T, Sheppard L.
    Br Med J (Clin Res Ed); 1987 Dec 12; 295(6612):1509-12. PubMed ID: 3122880
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of iron loading in transfusion-dependent thalassaemia.
    Pippard MJ, Letsky EA, Callender ST, Weatherall DJ.
    Lancet; 1978 Jun 03; 1(8075):1178-81. PubMed ID: 77945
    [Abstract] [Full Text] [Related]

  • 17. Delayed decrease in serum ferritin in polytransfused children with thalassemia major after continuous subcutaneous infusions of desferrioxamine.
    Schettini F, Mautone A, Cavallo L, Altomare M, Montagna O, Dell'Edera L.
    Acta Haematol; 1981 Jun 03; 66(2):96-101. PubMed ID: 6794319
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early iron overload in beta-thalassaemia major: when to start chelation therapy?
    Fargion S, Taddei MT, Gabutti V, Piga A, Di Palma A, Capra L, Fontanelli G, Avanzini A.
    Arch Dis Child; 1982 Dec 03; 57(12):929-33. PubMed ID: 7181522
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.